How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,013 results for

Glucose Tolerance Test 3 hour

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Diagnosis & Assessment of Hypertension - Lab Tests

) (Grade D); iii. Fasting blood glucose and/or glycated hemoglobin (A1c) (Grade D); iv. Serum total cholesterol, low-density lipoprotein, high-density lipoprotein (HDL), non-HDL cholesterol, and triglycerides (Grade D); lipids may be drawn fasting or non-fasting (Grade C). v. Standard 12-lead electrocardiography (Grade C). There is little direct evidence on which to base recommendations for laboratory testing. Thus, the recommended tests have been based largely on expert opinion. However, the routine (...) ventricular hypertrophy (LVH) or a prior myocardial infarction, both of which portend a higher risk of future cardiovascular events and death . Finally, both the routine and optional investigations aid in the screening for some of the modifiable causes of hypertension. For example recurrent and/or severe hypokalemia may indicate the presence of primary hyperaldosteronism. When compared with oral glucose tolerance testing, a systematic review suggests that A1C and fasting glucose levels demonstrate

2018 Hypertension Canada

162. Pilot Study on the Effect of Orally Administered Bisphenol A on Glucose and Insulin Response in Nonobese Adults. Full Text available with Trip Pro

, and C-peptide were assessed at baseline, minutes 15, 30, 45, 60, and every 30 minutes for 2 hours in response to a glucose tolerance test.There was a significant condition × time interaction for total BPA (P < 0.001) such that BPA increased more rapidly in BPA-50 than BPA-4 and PL (P = 0.003) and increased more rapidly in BPA-4 than PL (P < 0.001). There were no significant condition × time interactions on glucose, insulin, and C-peptide. Significant condition main effects were observed for glucose (...) such that BPA-50 was significantly lower than PL (P = 0.036) and nearly lower for BPA-4 vs PL (P = 0.056). Significant condition main effects were observed such that insulin in BPA-50 was lower than BPA-4 (P = 0.021), and C-peptide in BPA-50 was lower than BPA-4 (t18 = 3.95; Tukey-adjusted P = 0.003). Glucose, insulin, and C-peptide areas under the curve for the 3-hour profile were significantly lower in BPA-50 vs PL (P < 0.05).Orally administered BPA protocol appeared feasible and has immediate effects

2019 Journal of the Endocrine Society Controlled trial quality: uncertain

163. blood glucose

blood glucose Glucose Tests Produced by In partnership with User Top Links Menu Search User Top Links Search Glucose Tests Also Known As Blood sugar Fasting blood sugar Blood glucose Oral Glucose Tolerance Test (OGTT or GTT) Urine glucose Formal Name Blood Glucose; Urine Glucose This article was last reviewed on 27 July 2016. This article was last modified on 24 October 2018. At a Glance Why Get Tested? To determine whether or not your blood glucose level is within normal ranges; to screen (...) fasting and after meals. For random and timed tests, follow the instructions given to you by your healthcare professional. There is another test called an oral glucose tolerance test (OGTT). It requires that the person fasts (as described above) for the first blood sample and then drink a liquid containing a specified amount of glucose; a further blood sample is then taken after 2 hours. This test cannot be performed at home, and must be done under supervision of a healthcare professional. Accordion

2012 Lab Tests Online UK

164. Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

prominently at the front of the document: Reproduced (translated) with permission of AACC, Washington, DC. This document (PID 11774) was approved by the AACC Board of Directors in November 2017.LABORATORY MEDICINE PRACTICE GUIDELINES Executive Summary 5 Preamble 34 Introduction 38 Chapter 1: Testing for common classes of relevant over-the-counter, prescribed, and non-prescribed drugs and illicit substances abused by pain management patients 47 Chapter 2: Specimen types and detection times 52 Chapter 3 (...) at baseline and randomly, but at minimum annually for low-risk patients (American College of Occupation- al and Environmental Medicine, APS-AAPM, ASIPP, University of Michigan Health System, VA/DoD). However, in patients with 8 LABORATORY MEDICINE PRACTICE GUIDELINES risk factors for misuse/abuse, more frequent monitoring is rec- ommended, but the optimal frequency for these patients has not been determined (3). Laboratory testing and its ability to identify non- compliance in pain management regimens

2018 American Academy of Pain Medicine

165. Abnormal glucose tolerance testing after gastric bypass. (Abstract)

Abnormal glucose tolerance testing after gastric bypass. Symptoms secondary to dumping have been suggested to help patients refrain from simple carbohydrate ingestion after Roux-en-Y gastric bypass (RYGB). During follow-up examinations, we noted many patients with weight regain complaining of fatigue shortly after eating. Thus, we decided to study the glucose tolerance test (GTT) results in a cohort of post-RYGB patients.A total of 63 RYGB patients, >6 months postoperatively, were studied (...) . Of the 63 patients, 43 had evidence of reactive hypoglycemia at 1-2 hours after the glucose load. Of these patients, 22 had a maximum/minimum glucose ratio >3:1, including 7 with a ratio >4:1.The results of the present study have demonstrated that an abnormal GTT result is a common finding after RYGB. Reactive hypoglycemia was found in 43 of 63 patients, with insulin values that do not support nesidioblastosis. It is our hypothesis, that rather than preventing simple carbohydrate ingestion, the induced

2013 Surgery for Obesity and Related Diseases

166. Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors

tests within a 24-hour period C-peptide AUC [ Time Frame: 10 weeks ] C-peptide area-under-the-curve (pmol/l x hr) during each of three identical meal tolerance tests within a 24-hour period Peak glucose and mean amplitude of glycemic excursions (MAGE) glucose values [ Time Frame: 10 weeks ] mg/dl Secondary Outcome Measures : Mean 24-hour systolic and diastolic blood pressure [ Time Frame: 10 weeks ] mmHg Daily maximum value, minimum value, and amplitude of systolic and diastolic blood pressure (...) will be the first full-scale, controlled feeding trial to determine whether TRF can improve 24-hour blood sugar control, 24-hour blood pressure, and cardiovascular disease risk factors even when food intake is matched to the control group. This clinical trial will also determine whether the benefits of TRF depend on the time of day that people eat. Participants will be assigned to one of three groups: (1) 'Early TRF' (eat between ~8 am-3 pm), (2) 'Mid-day TRF' (eat between ~1 pm - 8 pm), or (3) Control Schedule

2018 Clinical Trials

167. A High-Fat Compared with a High-Carbohydrate Breakfast Enhances 24-Hour Fat Oxidation in Older Adults. Full Text available with Trip Pro

indirect calorimetry. Insulin and glucose measures including insulin sensitivity were determined by an oral-glucose-tolerance test. Measures were taken at baseline and after the 4-wk intervention. Group-by-time interactions were determined by 2-factor repeated-measures mixed-model ANOVA. Pearson's correlation analyses were used to determine associations of 24-h RQs with metabolic measures after the intervention.There was a significant group-by-time interaction for change in the 24-h RQ [FB (mean ± SD (...) A High-Fat Compared with a High-Carbohydrate Breakfast Enhances 24-Hour Fat Oxidation in Older Adults. The ability to oxidize fat is associated with a lower risk of chronic metabolic disease. Preclinical data in mice showed that a high-fat "breakfast" increased 24-h fat oxidation relative to a high-carbohydrate breakfast.The objectives of this study were to determine whether the timing of macronutrient intake in humans affects daily fuel utilization and to examine associations between fuel

2018 Journal of Nutrition Controlled trial quality: uncertain

168. Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

for Study: 31 Years to 60 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients both sexes Age between 31 and 60 years Diagnosis of diabetes according ADA criteria: (Fasting blood glucose levels >125 mg/dl or postprandial blood glucose levels after an oral glucose tolerance test with 75 of oral glucose > 200 mg/dl, or glycosylated hemoglobin >6.5%). • Informed consent signed Exclusion Criteria: Women with confirmed or suspected pregnancy Women (...) Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2018 Clinical Trials

169. The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male

Other: Glucose solution Not Applicable Detailed Description: After a 12-hour fast, oral glucose or meal tolerance test was performed with blood samples drawn at time 0, 15, 30, 45, 90, 120, 150, and 180 min. Serum levels of glucose, insulin, and C-peptide were analyzed by biochemical autoanalyzer. The area under the curve (AUC) changes in blood glucose were computed by the trapezoidal method. Glycemic index(GI): the area under the glucose response curve after consumption of a test food divided (...) Outcome Measures : 1. Glycemic index(GI) 2. Glucose, insulin AUC(incremental area under the curve) 3. C-peptide [ Time Frame: 2 hour postprandial blood glucose, insulin, c-peptide ] Glycemic index (GI) was defined as the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference. Plasma glucose will be measured at baseline, 15

2013 Clinical Trials

170. Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study

restriction(FGR),and so on. Other Outcome Measures: The incidence of temporal and distant metabolic disorder of mother [ Time Frame: 2 months to 1 year after delivery ] After about 2 months after delivery when mother comes back for postpartum follow-up, some tests will be done, such as regular blood test,blood glucose(fasting and 2 hours after meal), urine regular test and so on. Child growth measures [ Time Frame: 2 months to 1 year after delivery ] Children's body weight and height will be firstly (...) trimester [ Time Frame: at the second gestational trimester(about 24-28 gestational weeks) ] The results of oral glucose tolerance test(OGTT) at the second gestational trimester(about 24-28 gestational weeks) which is used to diagnose GDM will be recorded to analysis the incidence of GDM at the second gestational trimester. Secondary Outcome Measures : Gestational outcomes [ Time Frame: After delivery ] The adverse gestational outcomes will be recorded. For example: GDM, preeclampsia,fetal growth

2013 Clinical Trials

171. Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes

Intervention/treatment Phase Gestational Diabetes Behavioral: Blood glucose testing Not Applicable Detailed Description: This study is a prospective randomized, non-inferiority clinical trial of pregnant women diagnosed with gestational diabetes. Patients with GDM diagnosed between 20 weeks 0 days and 32 weeks 0 days of gestation will be recruited. Diagnosis of GDM will be based on Carpenter and Coustan criteria for an abnormal 3-hr 100 gram oral glucose tolerance test, as currently supported (...) by the American College of Obstetricians and Gynecologists (ACOG). Patients whose 1-hr, 50 gram oral glucose challenge test exceeds 200 mg/dl will not require a 3-hr oral glucose tolerance test (OGTT). If the patient meets the inclusion and exclusion criteria listed below, she will be offered participation in the trial and randomized to every day blood glucose testing or every other day blood glucose testing for the remainder of her pregnancy. After the diagnosis of GDM, and before recruitment to the study

2013 Clinical Trials

172. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. (Abstract)

Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. In this multicenter trial, the effects of nebivolol added to an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) were assessed in patients with hypertension (diastolic blood pressure [DBP] 80-110 mm Hg) and prediabetes (fasting blood glucose 100-125 mg/dL and/or 2-hour oral glucose tolerance test [OGTT] 140-199 mg/dL). After a 4-week run-in period (...) (in which lisinopril [10 mg/d] or losartan [50 mg/d] treatment was initiated), patients with DBP 90-110 mm Hg were randomized (2:2:1) to 12-week, double-blind treatment with nebivolol (n=223; 5-40 mg/d), hydrochlorothiazide (HCTZ; n=212; 12.5-25 mg/d), or placebo (n=102), titrated to achievement of 130/80 mm Hg. The primary outcome measure was DBP (last observation carried forward, intent to treat population); secondary measures included systolic blood pressure (SBP) and glucose levels. At baseline

2013 Journal of clinical hypertension (Greenwich, Conn.) Controlled trial quality: uncertain

173. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): a double-blind, randomized, placebo-controlled clinical trial. (Abstract)

on plasma glucose after a 2 hour-75 g oral glucose tolerance test (2hrPC glucose), insulin sensitivity and β-cell function.A total of 71 participants with serum 25(OH)D ≤65 nmol/L, impaired fasting glucose and elevated glycated hemoglobin were randomly assigned to receive 28 000 IU of vitamin D3 (VitD; n = 35) or placebo (n = 36) in cheese once weekly for 24 weeks. The primary outcome was the change in 2hPC glucose. Secondary outcomes were fasting glucose, fasting and postprandial insulin, indices (...) of insulin sensitivity and β-cell function, glycated hemoglobin and lipid profile. Participants underwent an oral glucose tolerance test to determine 2hPC glucose.Mean baseline serum 25(OH)D was 48.1 and 47.6 nmol/L in the VitD and placebo groups, respectively. Serum 25(OH)D significantly increased to 98.7 nmol/L (51 nmol/L increase; P < .0001) in the VitD group. No significant differences in fasting ( P = .42) or 2hPC glucose ( P = .55) or other indices of glucose metabolism, including β-cell function

2016 obesity & metabolism Controlled trial quality: predicted high

174. Diabetes, glucose tolerance, and the risk of sudden cardiac death. Full Text available with Trip Pro

44 years, 52.6 % male, follow-up duration 35-41 years) was divided into diabetes patients (n = 82), subjects with IGT (n = 3806, plasma glucose ≥9.58 mmol/l in one-hour glucose tolerance test), and controls (n = 6706).Diabetes patients had an increased risk of SCD after adjustment confounders (hazard ratio 2.62, 95 % confidence interval 1.46-4.70, p = 0.001) but risk for non-sudden cardiac death was similarly increased and the proportion of SCD of cardiac deaths was not increased. The SCD risk (...) Diabetes, glucose tolerance, and the risk of sudden cardiac death. Diabetes predisposes to sudden cardiac death (SCD). However, it is uncertain whether greater proportion of cardiac deaths are sudden among diabetes patients than other subjects. It is also unclear whether the risk of SCD is pronounced already early in the course of the disease. The relationship of impaired glucose tolerance (IGT) and SCD is scarcely documented.A general population cohort of 10594 middle-aged subjects (mean age

2016 BMC Cardiovascular Disorders

175. Effects of the internal circadian system and circadian misalignment on glucose tolerance in chronic shift workers. Full Text available with Trip Pro

Effects of the internal circadian system and circadian misalignment on glucose tolerance in chronic shift workers. Shift work is a risk factor for diabetes. The separate effects of the endogenous circadian system and circadian misalignment (ie, misalignment between the central circadian pacemaker and 24-hour environmental/behavioral rhythms such as the light/dark and feeding/fasting cycles) on glucose tolerance in shift workers are unknown.The objective of the study was to test the hypothesis (...) that the endogenous circadian system and circadian misalignment separately affect glucose tolerance in shift workers, both independently from behavioral cycle effects.A randomized, crossover study with two 3-day laboratory visits.Center for Clinical Investigation at Brigham and Women's Hospital.Healthy chronic shift workers.The intervention included simulated night work comprised of 12-hour inverted behavioral and environmental cycles (circadian misalignment) or simulated day work (circadian alignment

2016 Journal of Clinical Endocrinology and Metabolism Controlled trial quality: uncertain

176. Effect of an Acute Bout of Kettlebell Exercise on Glucose Tolerance in Sedentary Men: A Preliminary Study Full Text available with Trip Pro

Effect of an Acute Bout of Kettlebell Exercise on Glucose Tolerance in Sedentary Men: A Preliminary Study Impaired glucose tolerance can have significant health consequences. The purposes of this preliminary study were to examine whether a single session of kettlebell exercise improves acute post-exercise glucose tolerance in sedentary individuals, and whether it was as effective as high-intensity interval running. Six sedentary male subjects underwent a two-hour oral glucose tolerance test (...) following three different conditions: 1) control (no exercise); 2) kettlebell exercise (2 sets of 7 exercises, 15 repetitions per exercise with 30 seconds rest between each exercise); or 3) high-intensity interval running (10 one-minute intervals at a workload corresponding to 90% VO2max interspersed with one-minute active recovery periods). Blood glucose and insulin levels were measured before (0 minutes), and 60 and 120 minutes after glucose ingestion. Both kettlebell and high-intensity interval

2016 International journal of exercise science

177. The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance

an oral glucose tolerance test at the beginning and end of a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate. They will consume their intervention products daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12. Study Design Go to Layout table for study information Study Type (...) to Primary Outcome Measures : change oral glucose tolerance [ Time Frame: week 0 4 hours ] sample taken at time point 0 change oral glucose tolerance [ Time Frame: week 0 4 hours ] sample taken at time point 15 minutes post glucola change oral glucose tolerance [ Time Frame: week 0 4 hours ] sample taken at time point 30 minutes post glucola change oral glucose tolerance [ Time Frame: week 0 4 hours ] sample taken at time point 60 minutes post glucola change oral glucose tolerance [ Time Frame: week 0 4

2016 Clinical Trials

178. Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del

glucose tolerance test (OGTT) protocol; and blood work for glucose and insulin at 30, 60, 90 and 120 minutes after the glucose load. This will be scheduled at a time that is convenient to the patient, with an attempt to coordinate with the patient's visit to the CF clinic prior to starting lumacaftor-ivacaftor combination drug. At the 2nd study visit (Visit 2), which will take place 3 months after starting the combination drug, the participant will again come to the Diabetes Center after an overnight (...) A subject is given an oral glucose load and insulin and glucose measurements are taken at specified time periods. Other Name: Oral Glucose tolerance test Outcome Measures Go to Primary Outcome Measures : Change in Fasting Glucose [ Time Frame: 3 months ] This will be compared from baseline to 3 months after starting the medication Change in Fasting Glucose [ Time Frame: 6 months ] This will compare baseline to 6 months after starting the medication Secondary Outcome Measures : Genetic risk score [ Time

2016 Clinical Trials

179. Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.

Placebo Comparator: Placebo Patients with IGT Drug: Placebo Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner Other Name: Calcined Magnesia Outcome Measures Go to Primary Outcome Measures : Fasting plasma glucose [ Time Frame: 90 days ] Before and after intervention by spectrophotometry 2 hour oral glucose tolerance test (2-h OGTT) [ Time Frame: 90 days ] Before and after intervention by spectrophotometry A1C [ Time Frame: 90 days ] Before and after intervention by high (...) Intervention/treatment Phase Impaired Glucose Tolerance Drug: Gymnema Sylvestre Drug: Placebo Phase 2 Detailed Description: The target is to evaluate the effect of the administration of Gymnema Sylvestre on glycemic control, insulin secretion and insulin sensibility on patients with IGT. The investigators will conduct a double-blind trial, randomized, placebo control group, each group 12 female and male patients, between 30 and 59 years old with IGT (2-h values in the oral glucose tolerance test [OGTT

2016 Clinical Trials

180. Glucose Tolerance, Meal Timing and MTNR1B

melatonin concentrations results in impaired glucose control and that this effect is stronger in homozygous MTNR1B risk carriers than in non-carriers. To do so we will test glucose tolerance using identical mixed meals under two dinner conditions: a) delayed dinner or Late Eating (LE): starting1 hour before usual bed time, b) advanced dinner or Early Eating (EE): starting 4 hours before habitual bed time, in a randomized, cross-over study design. These findings could support a clinical application (...) of meal timing with endogenous melatonin concentrations Behavioral: Dinner timing Glucose tolerance after a late diner (1 hour before habitual bedtime) differs from early dinner (4 hours before habitual bedtime) due to the concurrence of meal timing with different levels of endogenous melatonin. This effect can be different among risk allele carriers (G) or non-rick allele carriers (C) of the MTNR1B. Experimental: Late Dinner Timing Test the concurrence of meal timing with elevated endogenous

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>